These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3672504)

  • 1. A spectrophotometric method for the standardization of thromboplastin clot-promoting activity.
    Hussein KA; Al-Hassan JM
    Tohoku J Exp Med; 1987 Sep; 153(1):5-9. PubMed ID: 3672504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence-based blood coagulation assay device for measuring activated partial thromboplastin time.
    Dudek MM; Kent N; Gustafsson KM; Lindahl TL; Killard AJ
    Anal Chem; 2011 Jan; 83(1):319-28. PubMed ID: 21121686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively.
    Panteleev MA; Ovanesov MV; Kireev DA; Shibeko AM; Sinauridze EI; Ananyeva NM; Butylin AA; Saenko EL; Ataullakhanov FI
    Biophys J; 2006 Mar; 90(5):1489-500. PubMed ID: 16326897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the spectrophotometric determination and the two-stage coagulation assay of tissue factor activity.
    Bolhuis PA; Sylva-Steenland RM; Tutuarima JA; Hische EA; van der Helm HJ
    Thromb Res; 1982 Aug; 27(4):429-34. PubMed ID: 7147213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of the prothrombin time: clinical results with a recombinant tissue factor reagent.
    Kolde HJ
    Haematologica; 1995; 80(2 Suppl):7-13. PubMed ID: 7628775
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurement of the viscoelastic properties of blood plasma clot formation in response to tissue factor concentration-dependent activation.
    Lakshmanan RS; Efremov V; O'Donnell JS; Killard AJ
    Anal Bioanal Chem; 2016 Sep; 408(24):6581-8. PubMed ID: 27311950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple spectrophotometric method for the determination of thrombin activity.
    Hussein KA; Al-Hassan JM
    Tohoku J Exp Med; 1987 Sep; 153(1):1-4. PubMed ID: 3672503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT.
    Konrad CJ; Markl TJ; Schuepfer GK; Schmeck J; Gerber HR
    Anesth Analg; 2000 Feb; 90(2):274-9. PubMed ID: 10648306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogenic substrate spectrophotometric assays for the measurement of clotting function.
    Aiyappa PA
    Ann N Y Acad Sci; 1981; 370():812-21. PubMed ID: 6943978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Hextend hemodilution on plasma coagulation kinetics in the rabbit: role of factor XIII-mediated fibrin polymer crosslinking.
    Nielsen VG
    J Surg Res; 2006 May; 132(1):17-22. PubMed ID: 16154147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of alpha2-macroglobulin with the coagulin clot in the American horseshoe crab, Limulus polyphemus: a potential role in stabilization from proteolysis.
    Asokan R; Armstrong MT; Armstrong PB
    Biol Bull; 2000 Oct; 199(2):190-2. PubMed ID: 11081729
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro effect of activated recombinant factor VII (rFVIIa) on coagulation properties of human blood at hypothermic temperatures.
    Kheirabadi BS; Delgado AV; Dubick MA; Scherer MR; Fedyk CG; Holcomb JB; Pusateri AE
    J Trauma; 2007 Nov; 63(5):1079-86. PubMed ID: 17993954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis.
    Kuo KH; Khan S; Rand ML; Mian HS; Brnjac E; Sandercock LE; Akula I; Julien JP; Pai EF; Chesney AE
    PLoS One; 2016; 11(3):e0149830. PubMed ID: 26934472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a multicenter study assessing the status of standardization of a recombinant thromboplastin for the control of oral anticoagulant therapy.
    Tripodi A; Chantarangkul V; Braga M; Poller L; ten Cate JW; van den Besselaar AM; Mannucci PM
    Thromb Haemost; 1994 Aug; 72(2):261-7. PubMed ID: 7831663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxaban.
    Harenberg J; Marx S; Krämer R; Giese C; Weiss C
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):637-41. PubMed ID: 21986465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
    Jámbor C; Reul V; Schnider TW; Degiacomi P; Metzner H; Korte WC
    Anesth Analg; 2009 Oct; 109(4):1023-8. PubMed ID: 19762725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple method for the determination of plasma extrinsic coagulant activity.
    Hussein KA; Medoukh NT
    Tohoku J Exp Med; 1986 Oct; 150(2):103-16. PubMed ID: 3810638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the tissue thromboplastin during the coagulation-fibrinolytic process--ultrastructural changes.
    Hasegawa H; Nagata H; Murao M
    Thromb Haemost; 1977 Jun; 37(3):541-8. PubMed ID: 578034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory standardization and quality control in anticoagulant therapy].
    Brink S; Cloete H; Roberts R; Holm W
    S Afr Med J; 1976 Feb; 50(7):205-8. PubMed ID: 816017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The standardization of the prothrombin time for the control of anticoagulant therapy.
    Biggs R
    Thromb Diath Haemorrh Suppl; 1968; 35():87-92. PubMed ID: 5761075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.